Madaus Martin D — SEC Form 4 filings
SEC reporting owner CIK 1310268. 18 Form 4 filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2024-02-13 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 4 filings — 13,800 shares, $905,770 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: purchase of 5,445 shares @ $55.24 ($300,760) in HOLOGIC INC, filed 2025-05-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REPLIGEN CORP (RGEN) | Director | 5 | 3 legs · 3,415 sh · $403,606 | — | 6 |
| HOLOGIC INC (HOLX) | Director | 5 | 1 leg · 5,445 sh · $300,760 | — | 8 |
| Azenta, Inc. (AZTA) | Interim CEO | 6 | 1 leg · 4,940 sh · $201,404 | — | 4 |
| Quanterix Corp (QTRX) | Director | 1 | — | — | 2 |
| HAEMONETICS CORP (HAE) | Director | 1 | — | — | 1 |
Form 4 filings — Madaus Martin D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | Azenta, Inc. (AZTA) | Grant/award (A): 36,653 @ $0 | EDGAR |
| 2026-07-28 | 4 | HAEMONETICS CORP (HAE) | Grant/award (A): 2,538 | EDGAR |
| 2026-05-18 | 4 | REPLIGEN CORP (RGEN) | Grant/award (A): 995 @ $0 · Grant/award (A): 2,239 (derivative) @ $0 | EDGAR |
| 2026-04-09 | 4 | HOLOGIC INC (HOLX) | Disposition to issuer (D): 5,396 · Disposition to issuer (D): 5,445 · Disposition to issuer (D): 1,016 (derivative) · Disposition to issuer (D): 5,535 (derivative) | EDGAR |
| 2026-03-02 | 4 | HOLOGIC INC (HOLX) | Grant/award (A): 3,190 | EDGAR |
| 2026-02-06 | 4 | Azenta, Inc. (AZTA) | Grant/award (A): 5,663 (derivative) | EDGAR |
| 2025-11-25 | 4/A | Azenta, Inc. (AZTA) | Holdings only — no transactions reported | EDGAR |
| 2025-08-12 | 4 | REPLIGEN CORP (RGEN) | Purchase (P): 1,800 @ $112.13 | EDGAR |
| 2025-05-19 | 4 | REPLIGEN CORP (RGEN) | Grant/award (A): 973 @ $0 · Grant/award (A): 1,800 (derivative) @ $0 | EDGAR |
| 2025-05-09 | 4 | HOLOGIC INC (HOLX) | Purchase (P): 5,445 @ $55.24 | EDGAR |
| 2025-02-28 | 4 | HOLOGIC INC (HOLX) | Grant/award (A): 1,864 · Grant/award (A): 5,535 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Azenta, Inc. (AZTA) | Grant/award (A): 4,040 (derivative) | EDGAR |
| 2025-01-06 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 7,435 @ $0 · Grant/award (A): 15,821 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | HOLOGIC INC (HOLX) | Grant/award (A): 342 | EDGAR |
| 2024-11-19 | 4 | Azenta, Inc. (AZTA) | Purchase (P): 4,940 @ $40.77 | EDGAR |
| 2024-06-14 | 4 | REPLIGEN CORP (RGEN) | Purchase (P): 915 @ $124.54 · Purchase (P): 700 @ $125.46 | EDGAR |
| 2024-05-20 | 4 | REPLIGEN CORP (RGEN) | Grant/award (A): 701 @ $0 · Grant/award (A): 1,376 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | Azenta, Inc. (AZTA) | Grant/award (A): 2,465 @ $65.93 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1310268 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →